Cougar Biotechnology Appoints Vice President of Clinical Research and Development.LOS ANGELES -- Cougar cougar: see puma. cougar or puma or mountain lion or panther Species (Puma concolor) of large, graceful cat that lives in a wide variety of habitats in the Americas, from southern Alaska to Patagonia. Biotechnology, Inc., a privately held biotechnology company, today announced the appointment of Gloria Lee, M.D., Ph.D. as Vice President of Clinical Research and Development. Dr. Lee brings 12 years of oncology clinical development to her role at Cougar. She will be responsible for the clinical development of Cougar's portfolio of drugs in development, including CB7630 and CB3304. "We are pleased to have someone of Gloria's caliber join Cougar at this important stage of the Company's development. Gloria's extensive clinical development experience coupled with her practical knowledge as a board certified board certified, adj the status of a dental specialist such as an orthodontist who has become a board diplomate by successfully completing the certification program of the recognized certification board in that area of practice. medical oncologist medical oncologist Oncology An oncologist who diagnoses and treats cancer with chemotherapy, hormones, biologicals, or immunologic agents; the MO becomes a cancer Pt's de facto primary care giver, and coordinates treatment provided by other specialists. will be tremendously useful to Cougar," said Dr. Arie Belldegrun, M.D., FACS FACS Fellow of the American College of Surgeons. FACS abbr. Fellow of the American College of Surgeons FACS fluorescence-activated cell sorter. , Vice Chairman of the Board of Directors of Cougar Biotechnology. Alan H. Auerbach, Chief Executive Officer and President of Cougar Biotechnology, added, "Gloria brings to Cougar a wealth of clinical development expertise in the field of oncology that will be very valuable in guiding the direction of Cougar's clinical development program." Dr. Lee joins Cougar from Chiron Corporation, where she held the position of Senior Director, Clinical Development-Oncology since 2003. Prior to Chiron, Dr. Lee was Senior Therapeutic Expert in Oncology at Hoffman La Roche from 1999 to 2003. Dr Lee also served in a variety of clinical development positions at Rhone Poulenc Rorer (now Aventis) from 1994 through 1999 including the position of Associate Director of Medical Affairs where Dr. Lee was responsible for the clinical development of the anticancer drug anticancer drug see antineoplastic. anticancer drug Chemotherapeutic, see there Taxotere in breast cancer. Dr. Lee is a board certified medical oncologist and holds an M.D. from The University of Miami This article is about the university in Coral Gables, Florida. For the university in Oxford, Ohio, see Miami University. The University of Miami (also known as Miami of Florida,[2] UM,[3] or just The U School of Medicine and a Ph.D. in molecular biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller from Columbia University. About Cougar Biotechnology Cougar Biotechnology, Inc. is a Los Angeles-based private biotechnology company established to in-license and develop early clinical stage drugs, with a specific focus on the field of oncology. Cougar's oncology portfolio includes CB7630, which has completed Phase I clinical trials in prostate cancer and CB3304 which is currently being tested in a Phase I trial in non-Hodgkin's lymphoma. Further information about Cougar Biotechnology can be found at www.cougarbiotechnology.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion